Barclays Initiates Coverage On NuVasive with Overweight Rating, Announces Price Target of $53
Barclays analyst Matt Miksic initiates coverage on NuVasive (NASDAQ:NUVA) with a Overweight rating and announces Price Target of $53.
Barclays Initiates Coverage On Medtronic with Equal-Weight Rating, Announces Price Target of $90
Barclays analyst Matt Miksic initiates coverage on Medtronic (NYSE:MDT) with a Equal-Weight rating and announces Price Target of $90.
Barclays Initiates Coverage On Globus Medical with Overweight Rating, Announces Price Target of $69
Barclays analyst Matt Miksic initiates coverage on Globus Medical (NYSE:GMED) with a Overweight rating and announces Price Target of $69.
Rosenblatt Initiates Coverage On Bentley Systems with Buy Rating, Announces Price Target of $37
Rosenblatt analyst Blair Abernethy initiates coverage on Bentley Systems (NASDAQ:BSY) with a Buy rating and announces Price Target of $37.
Analyst Thinks This Company’s Bone Marrow Cancer Treatment Can ‘Transform Paradigm’
SVB Leerink initiated coverage on CTI Biopharma Corp (NASDAQ:CTIC) with an Outperform rating and a $13 price target. CTIC is a commercial-stage…
Purple Biotech’s Assets Are First In Class For Solid Tumor Treatment, Analyst Says
HC Wainwright initiated coverage on Purple Biotech (NASDAQ:PPBT) with a Buy rating and a price target of $7. The company is working…
Merger Monday Vindicated This Analyst Who Nailed BP’s Offer Price As Energy M&A Heats Up
On Oct. 4, Wells Fargo & Co. (NYSE: WFC) analyst Michael Blum initiated coverage of Archaea Energy Inc.
PPG Analyst Expects Better Pricing and Cost To Overshadow Volume Headwinds
KeyBanc analyst Aleksey Yefremov initiated coverage of PPG Industries, Inc (NYSE:PPG) with an Overweight rating and a $127 price target. The central…
Analyst Sees A Leader In Solid Tumor Cell Therapy In This Stock
HC Wainwright initiated coverage of Lyell Immunopharma Inc (NASDAQ:LYEL) with a Buy rating and a price target of $12 per share. Lyell…
William Blair Initiates Coverage On Wolfspeed with Outperform Rating
William Blair analyst Jed Dorsheimer initiates coverage on Wolfspeed (NYSE:WOLF) with a Outperform rating.